Ligand Pharmaceuticals Inc (LGND)
72.23
+0.77
(+1.08%)
USD |
NASDAQ |
May 02, 16:00
72.23
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Gross Profit (Quarterly): 26.46M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 26.46M |
September 30, 2023 | 29.38M |
June 30, 2023 | 24.70M |
March 31, 2023 | 40.26M |
December 31, 2022 | 28.77M |
September 30, 2022 | 45.07M |
June 30, 2022 | 37.76M |
March 31, 2022 | 31.82M |
December 31, 2021 | 24.90M |
September 30, 2021 | 53.39M |
June 30, 2021 | 54.08M |
March 31, 2021 | 47.00M |
December 31, 2020 | 35.39M |
September 30, 2020 | 35.50M |
June 30, 2020 | 33.78M |
March 31, 2020 | 28.48M |
December 31, 2019 | 25.07M |
September 30, 2019 | 21.66M |
June 30, 2019 | 22.58M |
March 31, 2019 | 39.63M |
December 31, 2018 | 56.64M |
September 30, 2018 | 44.20M |
June 30, 2018 | 88.91M |
March 31, 2018 | 55.37M |
December 31, 2017 | 48.73M |
Date | Value |
---|---|
September 30, 2017 | 30.99M |
June 30, 2017 | 27.09M |
March 31, 2017 | 28.93M |
December 31, 2016 | 35.29M |
September 30, 2016 | 20.62M |
June 30, 2016 | 18.80M |
March 31, 2016 | 28.69M |
December 31, 2015 | 20.31M |
September 30, 2015 | 16.45M |
June 30, 2015 | 15.82M |
March 31, 2015 | 13.53M |
December 31, 2014 | 19.00M |
September 30, 2014 | 13.48M |
June 30, 2014 | 9.422M |
March 31, 2014 | 13.51M |
December 31, 2013 | 13.42M |
September 30, 2013 | 10.47M |
June 30, 2013 | 8.366M |
March 31, 2013 | 10.99M |
December 31, 2012 | 11.31M |
September 30, 2012 | 5.692M |
June 30, 2012 | 5.307M |
March 31, 2012 | 5.481M |
December 31, 2011 | 10.88M |
September 30, 2011 | 5.038M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
21.66M
Minimum
Sep 2019
54.08M
Maximum
Jun 2021
34.00M
Average
31.82M
Median
Mar 2022
Gross Profit (Quarterly) Benchmarks
ANI Pharmaceuticals Inc | 78.23M |
ADMA Biologics Inc | 31.09M |
Viking Therapeutics Inc | -- |
Corcept Therapeutics Inc | 133.53M |
Palatin Technologies Inc | 1.936M |